Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

Go back to Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
(NASDAQ: PGEN) Delayed: 7.78 -0.09 (1.14%)
Previous Close $7.87    52 Week High
Open $7.98    52 Week Low
Day High $8.04    P/E N/A 
Day Low $7.70    EPS
Volume 9,578,103